First Time Loading...

Entera Bio Ltd
NASDAQ:ENTX

Watchlist Manager
Entera Bio Ltd Logo
Entera Bio Ltd
NASDAQ:ENTX
Watchlist
Price: 2 USD -4.31% Market Closed
Updated: Jun 8, 2024

Entera Bio Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Entera Bio Ltd
Net Change in Cash Peer Comparison

Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Entera Bio Ltd
NASDAQ:ENTX
Net Change in Cash
-$1.3m
CAGR 3-Years
42%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Net Change in Cash
-$3.2m
CAGR 3-Years
-94%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Net Change in Cash
$21.4m
CAGR 3-Years
21%
CAGR 5-Years
36%
CAGR 10-Years
7%
B
BioLine RX Ltd
TASE:BLRX
Net Change in Cash
-$6.3m
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
5%
Urogen Pharma Ltd
NASDAQ:URGN
Net Change in Cash
$94.9m
CAGR 3-Years
89%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Net Change in Cash
-₪40.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Entera Bio Ltd's Net Change in Cash?
Net Change in Cash
-1.3m USD

Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Net Change in Cash amounts to -1.3m USD.

What is Entera Bio Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
21%

Over the last year, the Net Change in Cash growth was 90%. The average annual Net Change in Cash growth rates for Entera Bio Ltd have been 42% over the past three years , 21% over the past five years .